Review: taking Gravol and Zopiclone together


Summary

Drug interactions are reported among people who take Gravol and Zopiclone together. This review analyzes the effectiveness and drug interactions between Gravol and Zopiclone. It is created by eHealthMe based on reports of 107 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Gravol

Gravol has active ingredients of dimenhydrinate. It is often used in nausea. (latest outcomes from Gravol 1,252 users)

Zopiclone

Zopiclone has active ingredients of eszopiclone. It is often used in insomnia. (latest outcomes from Zopiclone 12,458 users)

On Sep, 16, 2016

107 people who take Gravol, Zopiclone are studied.


Number of reports submitted per year:

Gravol and Zopiclone drug interactions.

Drug effectiveness over time:

Gravol:
  • < 1 month: 100.0% - (2 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Zopiclone:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Gravol:
  • female: 28.0% - (2 of 7 people)
  • male: 100.0% - (1 of 1 people)
Zopiclone:
  • female: 14.0% - (1 of 7 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Gravol:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 66.0% - (2 of 3 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 2 people)
  • 60+: 0.0% - (0 of 0 people)
Zopiclone:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 3 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • platelet count decreased
  • sepsis
  • cellulitis
  • pneumonia
  • abdominal discomfort
  • abdominal distension
  • abdominal pain
  • abdominal pain upper
  • abscess
  • acute respiratory distress syndrome
1 - 6 months:
  • sudden death
6 - 12 months:
  • breathlessness
  • pain - muscles
  • tired eyes
  • chest pain
  • crackles lung
  • b-cell lymphoma
  • dry skin
  • ureteric obstruction
  • blood alkaline phosphatase increased
  • fear
1 - 2 years:
  • b-cell lymphoma
  • ureteric obstruction
  • pneumonia
  • renal failure acute
  • vertigo positional
2 - 5 years:
  • b-cell lymphoma
  • ureteric obstruction
  • blood alkaline phosphatase increased
  • renal failure acute
  • vertigo positional
5 - 10 years:
  • sense of oppression
  • fear
  • hallucination, auditory
  • long-term memory loss
  • paranoia
10+ years:
  • breathlessness
  • pain - muscles
  • tired eyes
  • chest pain
  • crackles lung
  • dry skin
not specified:
  • nausea
  • haemoglobin decreased
  • pneumonia
  • abdominal pain
  • peripheral motor neuropathy
  • cough
  • arthralgia
  • ataxia
  • back pain
  • chest discomfort

Most common drug interactions by gender *:

female:
  • breathlessness
  • pneumonia
  • pain - muscles
  • tired eyes
  • chest pain
  • ureteric obstruction
  • abdominal pain
  • crackles lung
  • fatigue
  • haemoglobin decreased
male:
  • pleural effusion
  • sudden death
  • tumour lysis syndrome
  • chills
  • cough
  • haemoglobin decreased
  • nausea
  • pyrexia
  • adenocarcinoma
  • asthenia

Most common drug interactions by age *:

10-19:
  • peripheral motor neuropathy
  • peripheral sensory neuropathy
  • anaphylactic shock
  • hospitalisation
  • tachycardia
20-29:
  • abdominal pain
  • arthralgia
  • concussion
  • dehydration
  • depression
  • diarrhoea
  • haemoglobin decreased
  • joint swelling
  • mobility decreased
  • nausea
30-39:
  • grand mal convulsion
  • abdominal discomfort
  • abdominal distension
  • abdominal pain
  • abdominal pain upper
  • abscess
  • anaemia
  • anxiety
  • arthralgia
  • asthenia
40-49:
  • breathlessness
  • pain - muscles
  • tired eyes
  • chest pain
  • crackles lung
  • dry skin
  • dysgeusia
  • acute respiratory distress syndrome
  • alanine aminotransferase increased
  • anaesthetic complication vascular
50-59:
  • abdominal pain
  • deep vein thrombosis
  • nausea
  • renal failure acute
  • gastrointestinal stoma complication
  • small intestinal obstruction
  • abdominal discomfort
  • acute generalised exanthematous pustulosis
  • amyotrophic lateral sclerosis
  • arthralgia
60+:
  • pneumonia
  • b-cell lymphoma
  • pleural effusion
  • ureteric obstruction
  • urinary retention
  • anxiety
  • back pain
  • bradycardia
  • peripheral motor neuropathy
  • renal failure acute

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Gravol and Zopiclone?

Can you answer these questions?

More questions for: Gravol, Zopiclone

You may be interested in these reviews

More reviews for: Gravol, Zopiclone

On eHealthMe, Gravol (dimenhydrinate) is often used to treat nausea. Zopiclone (eszopiclone) is often used to treat insomnia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.